2014
DOI: 10.1186/1741-7007-12-47
|View full text |Cite
|
Sign up to set email alerts
|

Neuronal deletion of GSK3β increases microtubule speed in the growth cone and enhances axon regeneration via CRMP-2 and independently of MAP1B and CLASP2

Abstract: BackgroundIn the adult central nervous system, axonal regeneration is abortive. Regulators of microtubule dynamics have emerged as attractive targets to promote axonal growth following injury as microtubule organization is pivotal for growth cone formation. In this study, we used conditioned neurons with high regenerative capacity to further dissect cytoskeletal mechanisms that might be involved in the gain of intrinsic axon growth capacity.ResultsFollowing a phospho-site broad signaling pathway screen, we fou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
67
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 82 publications
(71 citation statements)
references
References 64 publications
4
67
0
Order By: Relevance
“…82 Several reports provide evidence that GSK3b inhibition is associated with enhanced neuronal growth. [83][84][85] In summary, siRTP801-dependent potentiation of PI3K pathway signaling in RGCs via paracrine secretion of neurotrophins by activated glia combined with siRTP801-mediated activation of both mTORC1 and mTORC2 in RGCs themselves may be responsible for the observed increased survival and longer axon/neurite growth seen after siRTP801 treatment both in vitro (mixed retinal cultures) and in vivo. The challenge remains for the development of novel neuroprotective and axon regenerative therapies that can be used for the benefit of patients.…”
Section: Discussionmentioning
confidence: 99%
“…82 Several reports provide evidence that GSK3b inhibition is associated with enhanced neuronal growth. [83][84][85] In summary, siRTP801-dependent potentiation of PI3K pathway signaling in RGCs via paracrine secretion of neurotrophins by activated glia combined with siRTP801-mediated activation of both mTORC1 and mTORC2 in RGCs themselves may be responsible for the observed increased survival and longer axon/neurite growth seen after siRTP801 treatment both in vitro (mixed retinal cultures) and in vivo. The challenge remains for the development of novel neuroprotective and axon regenerative therapies that can be used for the benefit of patients.…”
Section: Discussionmentioning
confidence: 99%
“…Downstream to Akt is glycogen synthase kinase 3 beta (GSK-3b) which plays a central role in axonal growth. Activated Akt phosphorylates GSK-3b at Ser9, inactivating its constitutive kinase activity (Grimes and Jope 2001), a process required for neuronal polarization (Jiang et al 2005;Yoshimura et al 2005), axon growth (Zhou et al 2004), regeneration (Liz et al 2014) and branching (Garrido et al 2007). GSK-3b also regulates microtubule extension at the growth cone (Fukata et al 2002;Cole et al 2004;Zhou et al 2004Yoshimura et al 2005.…”
Section: Adenosine a 2a Receptor Activation Increases Microtubule Dynmentioning
confidence: 98%
“…Several signaling pathways converge onto microtubules to promote axon regeneration in the mammalian system (4). The GSK3-␤ pathway regulates the activity of microtubule-binding proteins such as cytoplasmic linker associated protein (CLASP), adenomatous polyposis coli, and CRMP2 to coordinate the stability, growth speed, and configuration of microtubules in growth cones and regulates axon growth (5,6). In addition to microtubule-binding proteins, posttranslational modifications of tubulin are believed to correlate with the dynamic properties of microtubules (7).…”
mentioning
confidence: 99%